[1] Aicher SA, Hegarty DM, Hermes SM. Corneal pain activates a trigemino- parabrachial pathway in rats. Brain Res 2014;1550:18–26.
[2] Aicher SA, Hermes SM, Hegarty DM. Corneal afferents differentially target thalamic- and parabrachial-projecting neurons in spinal trigeminal nucleus caudalis. Neuroscience 2013;232:182–93.
[3] Allen HN, Bobnar HJ, Kolber BJ. Left and right hemispheric lateralization of the amygdala in pain. Prog Neurobiol 2020;196:101891. doi:10.1016/ j.pneurobio.2020.101891.
[4] Ambriz-Tututi M, Rocha-Gonza´ lez HI, Castan˜ eda-Corral G, Araiza- Saldan˜ a CI, Caram-Salas NL, Cruz SL, Granados-Soto V. Role of opioid receptors in the reduction of formalin-induced secondary allodynia and hyperalgesia in rats. Eur J Pharmacol 2009;619:25–32.
[5] Arendt-Nielsen L, Nie H, Laursen MB, Laursen BS, Madeleine P, Simonsen OH, Graven-Nielsen T. Sensitization in patients with painful knee osteoarthritis. PAIN 2010;149:573–81.
[6] Barrot M. Tests and models of nociception and pain in rodents. Neuroscience 2012;211:39–50.
[7] Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology. J Clin Neurol 2012;8:89.
[8] Bianchi M, Martucci C, Biella G, Ferrario P, Sacerdote P. Increased substance P and tumor necrosis factor-a level in the paws following formalin injection in rat tail. Brain Res 2004;1019:255–8.
[9] Bianchi M, Panerai AE. Formalin injection in the tail facilitates hindpaw withdrawal reflexes induced by thermal stimulation in the rat: effect of paracetamol. Neurosci Lett 1997;237:89–92.
[10] Bigal ME, Ashina S, Burstein R, Reed ML, Buse D, Serrano D, Lipton RB. Prevalence and characteristics of allodynia in headache sufferers: a population study. Neurology 2008;70:1525–33.
[11] Boyer N, Dallel R, Artola A, Monconduit L. General trigeminospinal central sensitization and impaired descending pain inhibitory controls contribute to migraine progression. PAIN 2014;155:1196–205.
[12] Burgmer M, Gaubitz M, Konrad C, Wrenger M, Hilgart S, Heuft G, Pfleiderer B. Decreased gray matter volumes in the cingulo-frontal cortex and the amygdala in patients with fibromyalgia. Psychosom Med 2009;71:566–73.
[13] Burgos-Vega CC, Ahn DDU, Bischoff C, Wang W, Horne D, Wang J, Gavva N, Dussor G. Meningeal transient receptor potential channel M8 activation causes cutaneous facial and hindpaw allodynia in a preclinical rodent model of headache. Cephalalgia 2016;36:185–93.
[14] Burstein R, Yarnitsky D, Goor-Aryeh I, Ransil BJ, Bajwa ZH. An association between migraine and cutaneous allodynia. Ann Neurol 2000;47:614–24.
[15] Cadet R, Aigouy L, Woda A. Sustained hyperalgesia can be induced in the rat by a single formalin injection and depends on the initial nociceptive inputs. Neurosci Lett 1993;156:43–6.
[16] Campi LB, Jordani PC, Tenan HL, Camparis CM, Gonc¸ alves DAG. Painful temporomandibular disorders and central sensitization: implications for management—a pilot study. Int J Oral Maxillofac Surg 2017;46:104–10.
[17] Carrasquillo Y, Gereau RW. Activation of the extracellular signal-regulated kinase in the amygdala modulates pain perception. J Neurosci 2007;27: 1543–51.
[18] Carter ME, Han S, Palmiter RD. Parabrachial calcitonin gene-related peptide neurons mediate conditioned taste aversion. J Neurosci 2015; 35:4582–6.
[19] Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994; 53:55–63.
[20] Clavelou P, Dallel R, Orliaguet T, Woda A, Raboisson P. The orofacial formalin test in rats: effects of different formalin concentrations. PAIN 1995;62:295–301.
[21] Clavelou P, Pajot J, Dallel R, Raboisson P. Application of the formalin test to the study of orofacial pain in the rat. Neurosci Lett 1989;103:349–53.
[22] Crock LW, Kolber BJ, Morgan CD, Sadler KE, Vogt SK, Bruchas MR, Gereau RW. Central amygdala metabotropic glutamate receptor 5 in the modulation of visceral pain. J Neurosci 2012;32:14217–26.
[23] Crook RJ, Dickson K, Hanlon RT, Walters ET. Nociceptive sensitization reduces predation risk. Curr Biol 2014;24:1121–5.
[24] Fingleton C, Smart K, Moloney N, Fullen BM, Doody C. Pain sensitization in people with knee osteoarthritis: a systematic review and meta-analysis. Osteoarthr Cartil 2015;23:1043–56.
[25] Fu K-Y, Light AR, Maixner W. Long-lasting inflammation and long-term hyperalgesia after subcutaneous formalin injection into the rat hindpaw. J Pain 2001;2:2–11.
[26] Fu K-Y, Light AR, Maixner W. Relationship between nociceptor activity, peripheral edema, spinal microglial activation and long-term hyperalgesia induced by formalin. Neuroscience 2000;101:1127–35.
[27] Fu K-Y, Light AR, Matsushima GK, Maixner W. Microglial reactions after subcutaneous formalin injection into the rat hind paw. Brain Res 1999; 825:59–67.
[28] Geuter S, Reynolds Losin EA, Roy M, Atlas LY, Schmidt L, Krishnan A, Koban L, Wager TD, Lindquist MA. Multiple brain networks mediating stimulus–pain relationships in humans. Cereb Cortex 2020;30:4204–19.
[29] Gomez JL, Bonaventura J, Lesniak W, Mathews WB, Sysa-Shah P, Rodriguez LA, Ellis RJ, Richie CT, Harvey BK, Dannals RF, Pomper MG, Bonci A, Michaelides M. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine. Science 2017;357:503–7.
[30] Gonc¸ alves L, Dickenson AH. Asymmetric time-dependent activation of right central amygdala neurones in rats with peripheral neuropathy and pregabalin modulation. Eur J Neurosci 2012;36:3204–13.
[31] Greenspan JD, Slade GD, Bair E, Dubner R, Fillingim RB, Ohrbach R, Knott C, Diatchenko L, Liu Q, Maixner W. Pain sensitivity and autonomic factors associated with development of TMD: the OPPERA prospective cohort study. J Pain 2013;14:T63–74.e6.
[32] Guenthner CJ, Miyamichi K, Yang HH, Heller HC, Luo L. Permanent genetic access to transiently active neurons via TRAP: targeted recombination in active populations. Neuron 2013;78:773–84.
[33] Guettier J-M, Gautam D, Scarselli M, de Azua IR, Li JH, Rosemond E, Ma X, Gonzalez FJ, Armbruster BN, Lu H, Roth BL, Wess J. A chemical- genetic approach to study G protein regulation of cell function in vivo. Proc Natl Acad Sci 2009;106:19197–202.
[34] Han JS, Adwanikar H, Li Z, Ji G, Neugebauer V. Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats. Mol Pain 2010;6:10.
[35] Han JS, Li W, Neugebauer V. Critical role of calcitonin gene-related peptide 1 receptors in the amygdala in synaptic plasticity and pain behavior. J Neurosci 2005;25:10717–28.
[36] Igarashi H, Ikeda K, Onimaru H, Kaneko R, Koizumi K, Beppu K, Nishizawa K, Takahashi Y, Kato F, Matsui K, Kobayashi K, Yanagawa Y, Muramatsu S-I, Ishizuka T, Yawo H. Targeted expression of step-function opsins in transgenic rats for optogenetic studies. Sci Rep 2018;8:5435.
[37] Ikeda R, Takahashi Y, Inoue K, Kato F. NMDA receptor-independent synaptic plasticity in the central amygdala in the rat model of neuropathic pain. PAIN 2007;127:161–72.
[38] Jensen KB, Loitoile R, Kosek E, Petzke F, Carville S, Fransson P, Marcus H, Williams SCR, Choy E, Mainguy Y, Vitton O, Gracely RH, Gollub R, Ingvar M, Kong J. Patients with fibromyalgia display less functional connectivity in the brain’s pain inhibitory network. Mol Pain 2012;8: 1744–8069–8:32.
[39] Ji G, Neugebauer V. Pro- and anti-nociceptive effects of corticotropin- releasing factor (CRF) in central amygdala neurons are mediated through different receptors. J Neurophysiol 2008;99:1201–12.
[40] Ji G, Neugebauer V. Reactive oxygen species are involved in group I mGluR-mediated facilitation of nociceptive processing in amygdala neurons. J Neurophysiol 2010;104:218–29.
[41] Johnson AC, Tran L, Greenwood-Van Meerveld B. Knockdown of corticotropin-releasing factor in the central amygdala reverses persisten viscerosomatic hyperalgesia. Transl Psychiatry 2015;5:e517.
[42] Johnson AC, Tran L, Schulkin J, Meerveld BG-V. Importance of stress receptor-mediated mechanisms in the amygdala on visceral pain perception in an intrinsically anxious rat. Neurogastroenterol Motil 2012; 24:479–86.
[43] Jorge LL, Amaro E. Brain imaging in fibromyalgia. Curr Pain Headache Rep 2012;16:388–98.
[44] Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transpl 2013;48:452–8.
[45] Kato F, Sugimura YK, Takahashi Y. Pain-associated neural plasticity in the parabrachial to central amygdala circuit. Adv Exp Med Biol 2018; 1099:157–66.
[46] Kawai Y, Takami K, Shiosaka S, Emson PC, Hillyard CJ, Girgis S, MacIntyre I, Tohyama M. Topographic localization of calcitonin gene- related peptide in the rat brain: an immunohistochemical analysis. Neuroscience 1985;15:747–63.
[47] Kim J, Zhang X, Muralidhar S, LeBlanc SA, Tonegawa S. Basolateral to central amygdala neural circuits for appetitive behaviors. Neuron 2017; 93:1464–79.e5.
[48] Kocorowski LH, Helmstetter FJ. Calcitonin gene-related peptide released within the amygdala is involved in Pavlovian auditory fear conditioning. Neurobiol Learn Mem 2001;75:149–63.
[49] Kopruszinski CM, Navratilova E, Swiokla J, Dodick DW, Chessell IP, Porreca F. A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain. Cephalalgia 2020:033310242095979. doi: 10.1177/0333102420959794.
[50] Li J, Sheets PL. The central amygdala to periaqueductal gray pathway comprises intrinsically distinct neurons differentially affected in a model of inflammatory pain. J Physiol 2018;596:6289–305.
[51] Li K, Lin T, Cao Y, Light AR, Fu K-Y. Peripheral formalin injury induces 2 stages of microglial activation in the spinal cord. J Pain 2010;11:1056–65.
[52] Lister KC, Bouchard SM, Markova T, Aternali A, Denecli P, Pimentel SD, Majeed M, Austin J-S, de C, Williams AC, Mogil JS. Chronic pain produces hypervigilance to predator odor in mice. Curr Biol 2020;30: R866–7.
[53] Mahler SV, Aston-Jones G. CNO evil? considerations for the use of DREADDs in behavioral neuroscience. Neuropsychopharmacology 2018;43:934–6.
[54] Manvich DF, Webster KA, Foster SL, Farrell MS, Ritchie JC, Porter JH, Weinshenker D. The DREADD agonist clozapine N-oxide (CNO) is reverse-metabolized to clozapine and produces clozapine-like interoceptive stimulus effects in rats and mice. Sci Rep 2018;8:3840.
[55] Martinez VK, Saldana-Morales F, Sun JJ, Zhu PJ, Costa-Mattioli M, Ray RS. Off-target effects of clozapine-N-oxide on the chemosensory reflex are masked by high stress levels. Front Physiol 2019;10:512. doi: 10.3389/fphys.2019.00521.
[56] Miyazawa Y, Takahashi Y, Watabe AM, Kato F. Predominant synaptic potentiation and activation in the right central amygdala are independent of bilateral parabrachial activation in the hemilateral trigeminal inflammatory pain model of rats. Mol Pain 2018;14:174480691880710.
[57] Myers B, Greenwood-Van Meerveld B. Divergent effects of amygdala glucocorticoid and mineralocorticoid receptors in the regulation of visceral and somatic pain. Am J Physiol Liver Physiol 2010;298:G295–303.
[58] Nagai Y, Miyakawa N, Takuwa H, Hori Y, Oyama K, Ji B, Takahashi M, Huang XP, Slocum ST, DiBerto JF, Xiong Y, Urushihata T, Hirabayashi T, Fujimoto A, Mimura K, English JG, Liu J, Inoue Kichi, Kumata K, Seki C, Ono M, Shimojo M, Zhang MR, Tomita Y, Nakahara J, Suhara T, Takada M, Higuchi M, Jin J, Roth BL, Minamimoto T. Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys. Nat Neurosci 2020;23:1157–67.
[59] Neugebauer V. Amygdala pain mechanisms. Handbook Exp Pharmacol 2015;227:261–84.
[60] Neugebauer V. Metabotropic glutamate receptors—important modulators of nociception and pain behavior. PAIN 2002;98:1–8.
[61] Neugebauer V, Li W. Differential sensitization of amygdala neurons to afferent inputs in a model of arthritic pain. J Neurophysiol 2003;89: 716–27.
[62] Okamoto K, Kimura A, Donishi T, Imbe H, Goda K, Kawanishi K, Tamai Y, Senba E. Persistent monoarthritis of the temporomandibular joint region enhances nocifensive behavior and lumbar spinal Fos expression after noxious stimulation to the hindpaw in rats. Exp Brain Res 2006;170: 358–67.
[63] Okutsu Y, Takahashi Y, Nagase M, Shinohara K, Ikeda R, Kato F. Potentiation of NMDA receptor-mediated synaptic transmission at the parabrachial-central amygdala synapses by CGRP in mice. Mol Pain 2017;13:174480691770920.
[64] Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 6th ed. Amsterdam: Elsevier, 2007.
[65] Peng K-P, May A. Migraine understood as a sensory threshold disease. PAIN 2019;160:1494–501.
[66] Percie du Sert N, Rice ASC. Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain. Br J Pharmacol 2014; 171:2951–63.
[67] Prusator DK, Greenwood-Van Meerveld B. Amygdala-mediated mechanisms regulate visceral hypersensitivity in adult females following early life stress. PAIN 2017;158:296–305.
[68] Raboisson P, Dallel R. The orofacial formalin test. Neurosci Biobehav Rev 2004;28:219–26.
[69] Rodriguez E, Sakurai K, Xu J, Chen Y, Toda K, Zhao S, Han BX, Ryu D, Yin H, Liedtke W, Wang F. A craniofacial-specific monosynaptic circuit enables heightened affective pain. Nat Neurosci 2017;20:1734–43.
[70] Roelofs TJM, Verharen JPH, van Tilborg GAF, Boekhoudt L, van der Toorn A, de Jong JW, Luijendijk MCM, Otte WM, Adan RAH, Dijkhuizen RM. A novel approach to map induced activation of neuronal networks using chemogenetics and functional neuroimaging in rats: a proof-of- concept study on the mesocorticolimbic system. Neuroimage 2017;156: 109–18.
[71] Rogan SC, Roth BL. Remote control of neuronal signaling. Pharmacol Rev 2011;63:291–315.
[72] Sadler KE, McQuaid NA, Cox AC, Behun MN, Trouten AM, Kolber BJ. Divergent functions of the left and right central amygdala in visceral nociception. PAIN 2017;158:747–59.
[73] Sarlani E, Greenspan JD. Evidence for generalized hyperalgesia in temporomandibular disorders patients. PAIN 2003;102:221–6.
[74] Sato M, Ito M, Nagase M, Sugimura YK, Takahashi Y, Watabe AM, Kato F. The lateral parabrachial nucleus is actively involved in the acquisition of fear memory in mice. Mol Brain 2015;8:22.
[75] Shinohara K, Watabe AM, Nagase M, Okutsu Y, Takahashi Y, Kurihara H, Kato F. Essential role of endogenous calcitonin gene-related peptide in pain-associated plasticity in the central amygdala. Eur J Neurosci 2017; 46:2149–60.
[76] Sink KS, Davis M, Walker DL. CGRP antagonist infused into the bed nucleus of the stria terminalis impairs the acquisition and expression of context but not discretely cued fear. Learn Mem 2013;20:730–9.
[77] Smith JC. A review of strain and sex differences in response to pain and analgesia in mice. Comp Med 2019;69:490–500.
[78] Soma S, Yoshida J, Kato S, Takahashi Y, Nonomura S, Sugimura YK, R´ıos A, Kawabata M, Kobayashi K, Kato F, Sakai Y, Isomura Y. Ipsilateral- dominant control of limb movements in rodent posterior parietal cortex. J Neurosci 2019;39:485–502.
[79] Sugimura YK, Takahashi Y, Watabe AM, Kato F. Synaptic and network consequences of monosynaptic nociceptive inputs of parabrachial nucleus origin in the central amygdala. J Neurophysiol 2016;115: 2721–39.
[80] Todd AJ. Neuronal circuitry for pain processing in the dorsal horn. Nat Rev Neurosci 2010;11:823–36.
[81] Uddin O, Studlack P, Akintola T, Raver C, Castro A, Masri R, Keller A. Amplified parabrachial nucleus activity in a rat model of trigeminal neuropathic pain. Neurobiol Pain 2018;3:22–30.
[82] Vanini G. Sleep deprivation and recovery sleep rrior to a noxious inflammatory insult influence characteristics and duration of pain. Sleep 2016;39:133–42.
[83] Veinante P, Yalcin I, Barrot M. The amygdala between sensation and affect: a role in pain. J Mol Psychiatry 2013;1:9.
[84] Vierck CJ, Yezierski RP, Light AR. Long-lasting hyperalgesia and sympathetic dysregulation after formalin injection into the rat hind paw. Neuroscience 2008;153:501–6.
[85] Wilson TD, Valdivia S, Khan A, Ahn H-S, Adke AP, Martinez Gonzalez S, Sugimura YK, Carrasquillo Y. Dual and opposing functions of the central amygdala in the modulation of pain. Cell Rep 2019;29:332–46.e5.
[86] Wu Y, Willcockson HH, Maixner W, Light AR. Suramin inhibits spinal cord microglia activation and long-term hyperalgesia induced by formalin injection. J Pain 2004;5:48–55.
[87] Xu W, Lundeberg T, Wang Y, Li Y, Yu L-C. Antinociceptive effect of calcitonin gene-related peptide in the central nucleus of amygdala: activating opioid receptors through amygdala–periaqueductal gray pathway. Neuroscience 2003;118:1015–22.
[88] Zhang S-H, Yu J, Lou G-D, Tang Y-Y, Wang R-R, Hou W-W, Chen Z. Widespread pain sensitization after partial infraorbital nerve transection in MRL/MPJ mice. PAIN 2016;157:740–9.
論文の公開元へ
